PriMatrix for the Management of Diabetic Foot Ulcers
Prospective, Multi-center, Randomized, Controlled Trial Evaluating the Use of PriMatrix Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers
Sponsor: Integra LifeSciences Corporation
Listed as NCT03010319, this NA trial focuses on Diabetic Foot Ulcer and remains completed. Sponsored by Integra LifeSciences Corporation, it has been updated 21 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
-
Apr 2022 — May 2022 [monthly]
Completed NA
▶ Show 16 earlier versions
-
Apr 2021 — Apr 2022 [monthly]
Completed NA
-
Mar 2021 — Apr 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2020 — Nov 2020 [monthly]
Recruiting NA
-
Mar 2020 — May 2020 [monthly]
Recruiting NA
-
Nov 2019 — Mar 2020 [monthly]
Recruiting NA
-
Sep 2019 — Nov 2019 [monthly]
Recruiting NA
-
Apr 2019 — Sep 2019 [monthly]
Recruiting NA
-
Feb 2019 — Apr 2019 [monthly]
Recruiting NA
-
Aug 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jul 2017 — Dec 2017 [monthly]
Recruiting NA
-
Apr 2017 — Jul 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Integra LifeSciences Corporation
For direct contact, visit the study record on ClinicalTrials.gov .